Transgenic and genetic animal models

Hormones, Brain and Behavior Online

Volumn , Issue , 2009, Pages 2673-2709

  Keri, R A ^a   Siegel, R E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chimeric mouse; Congenic; Embryonic stem cell; Gene silencing; Genetic background; Knockout mouse; Recombinase; Reporter gene; Tet repressor; Transgenic mouse

Indexed keywords

EID: 84884772221     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008088783-8.00085-1     Document Type: Chapter

References (204)

1. Abe K., Rossoman K.L., Liu B., Ritola K.D., Chiang D., Campbell S.L., Burridge K., Der C.J. Vav2 is an activator of Cdc42, Rac1, and RhoA. Journal of Biological Chemistry 2000, 275:10141-10149.
2. Adams D.J., Biggs P.J., Cox T., et al. Mutagenic insertion and chromosome engineering resource (MICER). Nature Genetics 2004, 36:867-871.
3. Anisman H., Hayley S., Kelly O., Borowski T., Merali Z. Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: Mouse strain-dependent outcomes. Behavioral Neuroscience 2001, 115:443-454.
4. Austin C.P., Battery F., Bradley A., et al. The knockout mouse project. Nature 2004, 36:921-924.
5. Baird G.S., Zacharias D.A., Tsein R.Y. Cicular permutation and receptor insertion with green fluorescent proteins. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:11241-11246.
6. Balkan W., Colbert M., Bock C., Linney E. Transgenic indicator mice for studying activated retinoic acid receptors during development. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:3347-3351.
7. Balogh S.A., McDowell C.S., Stavenezer A.J., Denenberg V.H. A behavioral and neuroanatomical assessment of inbred substrain of 129 mice with behavioral comparisons to C57BL/6J mice. Brain Research 1999, 836:38-48.
8. Bartke A., Chandrashekar V., Turyn C., et al. Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgenic and knock-out mice. Proceedings of the Society for Experimental Biology and Medicine 1999, 222:113-123.
9. Basak O., Taylor V. Identification of self-replicating multipotent progenitors in the embryonic nervous system by high Notch activity and Hes5 expression. European Journal of Neuroscience 2007, 25:1006-1022.
10. Bennani-Baiti I.M., Asa S.L., Song D., Iratni R., Liebhaber S.A., Cooke N.E. DNase I hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:10655-10660.
11. Bewick G.A., Gardiner J.V., Dhillo W.S., et al. Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB Journal 2005, 19:1680-1682.
12. Bilkei-Gorzo A., Racz I., Michel K., Zimmer A., Klingmuller D., Zimmer A. Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds. Psychopharmacology 2004, 176:343-352.
13. Bishop J.O., Smith P. Mechanism of chromosomal integration of microinjected DNA. Molecular Biology and Medicine 1989, 6:283-298.
14. Boer U., Alejel T., Beimesche S., Cierny I., Krause D., Knepel W., Flugge G. CRE/CREB-driven up-regulation of gene expression by chronic social stress in CRE-luciferase transgenic mice: Reveral by antidepressant treatment. PLoS One 2007, 2:e431.
15. Boer U., Alejel T., Beimesche S., Cierny I., Krause D., Knepel W., Flugge G. CRE/CREB-driven up-regulation of gene expression by chronic social stress in CRE-luciferase transgenic mice: Reversal by antidepressant treatment. PLoS One 2007, 2:e431.
16. Bokar J.A., Keri R.A., Farmerie T.A., et al. Expression of the glycoprotein homone α-subunit gene in the placenta requires a function cyclic AMP response element, whereas a different cis-acting element mediates pituitary-specific expression. Molecular and Cellular Biology 1989, 9:5113-5122.
17. Brinster R.L., Allen J.M., Behringer R.R., Gelinas R.E., Palmiter R.D. Introns increase transcriptional efficiency in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 1988, 85:836-840.
18. Brinster R.L., Chen H.Y., Messing A., van Dyke T., Levine A.J., Palmiter R.D. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 1984, 37:367-379.
19. Brinster R.L., Chen H.Y., Trumbauer M.E., Senear A.W., Warren R., Palmiter R.D. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell 1981, 27:223-231.
20. Brocard J., Warot X., Wendling O., Messaddeq N., Vonesch J.-L., Chambon P., Metzger D. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:14559-14563.
21. Bronson S.K., Plaehn E.G., Kluckman K.D., Hagaman J.R., Maeda N., Smithies O. Single-copy transgenic mice with chosen site integration. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:9067-9072.
22. Capecchi M.R. The new mouse genetics: Altering the genome by gene targeting. Trends in Genetics 1989, 5:70-76.
23. Carr L.G., Habegger K., Spence J.P., Liu L., Lumeng L., Foroud T. Development of congenic rat strains for alcohol consumption derived from the alcohol-preferring and nonpreferring rats. Behavioral Genetic 2006, 36:285-290.
24. Chang K., Elledge S.J., Hannon G.J. Lessons from nature: MicroRNA-based shRNA libraries. Nature Methods 2006, 3:707-714.
25. Chauhan N.B., Lee J.M., Siegel G.J. Na, K-ATPase mRNA levels and plaque load in Alzheimer's disease. Journal of Molecular Neuroscience 1997, 9:151-166.
26. Chen J., Kelz M.B., Zeng G., et al. Transgenic animals with inducible, targeted gene expression in brain. Molecular Pharmacology 1998, 54:495-503.
27. Chevalier-Mariette C., Henry I., Montfort L., Capgras S., Forlani S., Muschler J., Nicolas J.-F. CpG content affects gene silencing in mice: Evidence from novel transgenes. Genome Biology 2003, 4:R53.
28. Chia R., Achilli F., Festing M.F.W., Fisher E.M.C. The origins and uses of mouse outbred stocks. Nature Genetics 2005, 1181:1186.
29. Chiocchetti A., Tolosano E., Hirsch E., Silengo L., Altruda F. Green fluorescent protein as a reporter of gene expression in transgenic mice. Biochimica et Biophysica Acta 1997, 1352:193-202.
30. Choi T., Huang M., Gorman C., Jaenisch R. A generic intron increases gene expression in transgenic mice. Molecular and Cellular Biology 1991, 11:3070-3074.
31. Choi D.S., Wang D., Dadgar J., Chang W.S., Messing R.O. Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice. Journal of Neuroscience 2002, 22:9905-9911.
32. Ciana P., Raviscioni M., Mussi P., et al. In vivo imaging of transcriptionally active estrogen receptors. Nature Medicine 2003, 9:82-86.
33. Clark A.J., Harold G., Yull F.E. Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice. Nucleic Acids Research 1997, 25:1009-1014.
34. Classon M., Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nature Reviews Cancer 2002, 2:910-917.
35. Cole T.J., Blendy J.A., Monaghan A.P., et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severly retards lung maturation. Genes and Development 1995, 9:1608-1621.
36. Constantini F., Lacy E. Introduction of a rabbit β-globin gene into the mouse germ line. Nature 1981, 294:92-94.
37. Contag C.H., Bachmann M.H. Advances in in vivo bioluminescence imaging of gene expression. Annual Review of Biomedical Engineering 2002, 4:235-260.
38. Crawley J.N., Belknap J.K., Collins A., et al. Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies. Psychopharmacology 1997, 132:107-124.
39. Crawley J.N., Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Hormones and Behavior 1997, 31:197-211.
40. Cryan J.F., Holmes A. The ascent of mouse: Advances in modeling human depression and anxiety. Nature Reviews Drug Discovery 2005, 4:775-790.
41. Cvetkovic B., Yang B., Williamson R.A., Sigmund C.D. Appropriate tissue- and cell-specific expression of a single copy human angiotensinogene transgene specifically targeted upstream of the HPRT locus by homologous recombination. Journal of Biological Chemistry 2000, 275:1073-1078.
42. Dancinger E., Mettling C., Vidal M., Morris R., Margolis F. Olfactory marker protein gene: Its structure and olfactory neuron-specific expression in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 1989, 86:8565-8569.
43. Dann C.T. New technology for an old favorite: Lentiviral transgenesis and RNAi in rats. Transgenic Research 2007, 16:571-580.
44. Dann C.T., Alvarado A.L., Hammer R.E., Garbers D.L. Heritable and stable gene knockdown in rats. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:11246-11251.
45. De Vries G.J., Rissman E.F., Simerly R.B., et al. A model system for study of sex chromosome effects on sexually dimorphic neural and behavioral traits. Journal of Neuroscience 2002, 22:9005-9014.
46. Deng C., Capecchi M.R. Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus. Molecular and Cellular Biology 1992, 12:3365-3371.
47. Dominguez-Salazar E., Bateman H.L., Rissman E.F. Background matters: The effects of estrogen receptor a gene disruption on male sexual behavior are modified by background strain. Hormones and Behavior 2004, 46:482-490.
48. Evans V., Hatzopoulos A., Aird W.C., Rayburn H.B., Rosenberg R.D., Kuivenhoven J.A. Targeting the Hprt locus in mice reveals differential regulation of Tie2 gene expression in the endothelium. Physiological Genomics 2000, 2:67-75.
49. Feng G., Mellor R.H., Bernstein M., et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000, 28:41-51.
50. Filipiak W.E., Saunders T.L. Advances in transgenic rat production. Transgenic Research 2006, 15:673-686.
51. Forrester W.C., Fernandez L.A., Grosschedl R. Nuclear matrix attachment regions antagonize methylation-dependent repression of long-range enhancer-promoter interactions. Genes and Development 1999, 13:3003-3014.
52. Forss-Petter S., Danielson P.E., Catsicas S., Battenberg E., Price J., Nerenberg M., Sutcliffe J.G. Transgenic mice expressing β-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron 1990, 5:187-197.
53. Friedrich G., Soriano P. Promoter traps in embyonic stem cells: A genetic screen to identify and mutate developmental genes in mice. Genes and Development 1991, 5:1513-1523.
54. Ganat Y.M., Silbereis J., Cave C., et al. Early postnatal astroglial cells produce multilineage precursers and neural stem cells in vivo. Journal of Neuroscience 2006, 26:8609-8621.
55. Garrick D., Fiering S., Martin D.I.K., Whitelaw E. Repeat-induced gene silencing in mammals. Nature Genetics 1998, 18:56-59.
56. Gaveriaux-RuffC., Kieffer B.L. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases. Pharmacology and Therapeutics 2007, 113:619-634.
57. Gerlai R. Gene-targeting studies of mammalian behavior: Is it the mutation of the background genotype?. Trends in Neuroscience 1996, 19:177-181.
58. Giraldo P., Montoliu L. Size matters: Use of YACs, BACs, and PACs in transgenic animals. Transgenic Research 2001, 10:83-103.
59. Glaser S., Anastassiadis K., Stewart A.F. Current issues in mouse genome engineering. Nature Genetics 2005, 37:1187-1193.
60. Gordon J.W., Ruddle F.H. Integration and stable germ line transmission of genes injected into mouse pronuclei. Science 1981, 214:1244-1246.
61. Gordon J.W., Scangos G.A., Plotkin D.J., Barbosa J.A., Ruddle F.H. Genetic transformation of mouse embryos by microinjection of purified DNA. Proceedings of the National Academy of Sciences of the United States of America 1980, 77:7380-7384.
62. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995, 268:1766-1769.
63. Graham D.L., Edwards S., Bachtell R.K., DiLeone R.J., Rios M., Self D.W. Dynamic BDNF activity in nucleus accumbens with cocaine uuse increases self-administration and relapse. Nature Neuroscience 2007, 10:1029-1037.
64. Graves R.A., Tontonoz P., Ross S.R., Spiegelman B.M. Identification of a potent adipocyte-specific enhancer: Involvement of an NF-1-like factor. Genes and Development 1991, 5:428-437.
65. Griebel G., Belzung C., Perrault G., Sanger D.J. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psycopharmacology (Berl) 2000, 148:164-170.
66. Gropp E., Shanabrough M., Borok E., et al. Agouti-related peptide-expressing neurons are mandatory for feeding. Nature Neuroscience 2005, 8:1289-1291.
67. Gross S., Piwinica-Worms D. Spying on cancer: Molecular imaging in vivo with genetically encoded reporters. Cancer Cell 2005, 7:5-15.
68. Gu H., Zou Y.R., Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993, 73:1155-1164.
69. Hadjantonakis A.-K., Dickinson M.E., Fraser S.E., Papaioannou V.E. Technicolor transgenics: Imaging tools for functional genomics in the mouse. Nature Reviews Genetics 2003, 4:613-625.
70. 2+ indicator proteins in transgenic mice under TET control. PLoS Biology 2004, 2:e163.
71. Hasty P., Rivera-Perez J., Bradley A. The length of homology required for gene targeting in embryonic stem cells. Molecular and Cellular Biology 1991, 11:5586-5591.
72. Hasty P., Rivera-Perez J., Chang C., Bradley A. Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells. Molecular and Cellular Biology 1991, 11:4509-4517.
73. +-ATPase activities in Alzheimer's disease brain. Neuroscience Letters 1998, 254:141-144.
74. Heim N., Garaschuk O., Friedrich M.W., et al. Improved calcium imaging in transgenic mice expressing a troponin C-based biosensor. Nature Methods 2007, 4:127-129.
75. Heyman R.A., Borrelli E., Lesley J., et al. Thymidine kinase obliteration: Creation of transgenic mice with controlled immune deficiency. Proceedings of the National Academy of Sciences of the United States of America 1989, 86:2698-2702.
76. Hide T., Hatakeyama J., Kimura-Yoshida C., et al. Genetic modifiers of otocephalic phenotypes in Otx2 heterozygous mutant mice. Development 2002, 129:4347-4357.
77. Hikida T., Jaaro-Peled H., Seshadri S., et al. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phentoypes detected by measures translatable to humans. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:14501-14506.
78. Holmes A., Lit Q., Murphy D.L., Gold E., Crawley J.N. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: The influence of genetic background. Genes, Brain and Behavior 2003, 2:365-380.
79. Impey A., Smith D.M., Obrietan K., Donahue R., Wade C., Storm D.R. Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nature Neuroscience 1998, 1:595-601.
80. Jakobovits A., Moore A.L., Green L.L., Vergara G.J., Maynard-Currie C.E., Austin H.A., Klapholz S. Germ-line transmission and expression of a human-derived yeast artificial chromosome. Nature 1993, 362:255-258.
81. Jasoni C.L., Todman M.G., Strumia M.M., Herbison A.E. Cell type-specific expression of a genetically encoded calcium indicator reveals intrinsic calcium oscillations in adult gonadotropin-releasing hormone neurons. Journal of Neuroscience 2007, 27:860-870.
82. Johnson T.M., Attardi L.D. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice. Cell Death and Differentiation 2006, 13:902-908.
83. Kamiya A., Kubo K., Tomoda T., et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nature Cell Biology 2005, 7:1167-1178.
84. Karatsoreos I.N., Wang A., Sasanian J., Silver R. A role for androgens in regulating circadian behavior and the suprachiasmatic nucleus. Endocrinology 2007, 148:5487-5495.
85. Karpova A.Y., Tervo D.G.R., Gray N.W., Svoboda K. Rapid and reversible chemical inactivation of synaptic transmission in genetically targeted neurons. Neuron 2005, 48:727-735.
86. Kelly M.A., Rubenstein M., Phillips T.J., et al. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. Journal of Neuroscience 1998, 18:3470-3479.
87. Keri R.A., Wolfe M.W., Saunders T.L., et al. The proximal promoter of the bovine luteinizing hormone β-subunit gene confers gonadotrope-specific expression and regulation by gonadotropin-releasing hormone, testosterone, and 17β-estradiol in transgenic mice. Molecular Endocrinology 1994, 8:1807-1816.
88. Knoll J.G., Wolfe C.A., Tobet S.A. Estrogen modulates neuronal movements within the developing preoptic area-anterior hypothalamus. European Journal of Neuroscience 2007, 26:1091-1099.
89. Knopfer T., Diez-Garcia J., Akemann W. Optical probing of neuronal circuit dynamics: Genetically encoded versus classical fluorescent sensors. Trends in Neuroscience 2006, 29:160-166.
90. Koopman P., Gubbay J., Vivian N., Goodfellow P., Lovell-Badge R. Male development of chromosomally female mice transgenic for Sry. Nature 1991, 351:117-121.
91. Kusek G.K., Wahlsten D., Herron B.J., Bolivar V.J., Flaherty L. Localization of two new X-linked quantitative trait loci controlling corpus callosum size in the mouse. Genes, Brain and Behavior 2007, 6:359-363.
92. Lamb B.T., Bardel K.A., Kulnane L.S., et al. Amyloid production and deposition in mutant amyloid precurser protein and presenilin-1 yeast artifical chromosome transgenic mice. Nature Neuroscience 1999, 2:695-697.
93. Lamb B.T., Sisodia S.S., Lawler A.M., et al. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice. Nature Genetics 1993, 5:22-30.
94. Lathe R. Mice, gene targeting and behavior: More than just genetic background. Trends in Neuroscience 1996, 19:183-186.
95. Lavitrano M., Carnaioni A., Fazio V.M., Dolci S., Farace M.G., Spadafora C. Sperm cells as vectors for introducing foreign DNA into eggs: Genetic transformation of mice. Cell 1989, 57:717-723.
96. Le Hir H., Nott A., Moore M.J. How introns influence and enhance eukaryotic gene expression. Trends in Biochemical Sciences 2003, 28:215-220.
97. LeCouter J.E., Kablar B., Whyte P.F., Ying C., Rudnicki M.A. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 1998, 125:4669-4679.
98. Lee T., Shah C., Xu E.Y. Gene trap mutagenesis: A functional genomics approach towards reproductive research. Molecular Human Reproduction 2007, 13:771-779.
99. Lernbecher T., Muller U., Wirth T. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 1993, 365:767-770.
100. Leung R.K.M., Whittaker P.A. RNA interference: From gene silencing to gene-specific therapeutics. Pharmacology and Therapeutics 2005, 107:222-239.
101. Lewandowski M. Conditional control of gene expression in the mouse. Nature Reviews Genetics 2001, 2:743-755.
102. Lin A.H., Luo J., Mondshein L.H., ten Dijke P., Vivien D., Contag C.H., Wyss-Coray T. Global analysis of Smad2/3-dependent TGF-β signaling in living mice reveals prominent tissue-specific responses to injury. Journal of Immunology 2005, 175:547-554.
103. Livet J., Weissman T.A., Kang H., Draft R.W., Lu J., Bennis R.A., Sanes J.R., Lichtman J.W. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 2007, 450:56-62.
104. Lo K.D., Zhenmin L., Rao C.V., Beck J., Lamb D.J. De novo testosterone production in luteinizing hormone receptor knockout mice after transplantation of leydig stem cells. Endocrinology 2004, 9:4011-4015.
105. Loonstra A., Vooijs M., Beverloo H.B., et al. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:9209-9214.
106. Maas R.L., Zeller R., Woychik R.P., Vogt T.F., Leder P. Disruption of formin-encoding transcripts in two mutant limb deformity alleles. Nature 1990, 346:853-855.
107. MacPhee M., Chepenik K.P., Liddell R.A., Nelson K.K., Siracusa L.D., Buchberg A.M. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 1995, 81:957-966.
108. Mansour S.L., Thomas K.R., Capecchi M.R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes. Nature 1988, 336:348-352.
109. Maretto S., Cordenonsi M., Dupont S., et al. Mapping Wnt/β-catenin signaling during mouse development and in coloractal tumors. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:3299-3304.
110. Markel P., Shu P., Ebeling C., Calson G.A., Nagle D.L., Smutko J.S., Moore K.J. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nature Genetics 1997, 17:280-284.
111. Martin S.E., Caplan N.J. Applications of RNA interference in mammalian systems. Annual Review of Genomics and Human Genetics 2007, 8:81-108.
112. Matsumoto K., Wassarman K.M., Wolffe A.P. Nuclear history of a pre-mRNA determine the translational activity of cytoplasmic mRNA. EMBO Journal 1998, 17:2107-2121.
113. Mayford M., Bach M.E., Huang Y.-Y., Wang L., Hawkins R.D., Kandel E.R. Control of memory formation through regulated expression of a CaMKII transgene. Science 1996, 274:1678-1683.
114. Meisler M.H. Insertional mutation of 'classical' and novel genes in transgenic mice. Trends in Genetics 1992, 8:341-349.
115. Mellon P.L., Windle J.J., Goldsmith P.C., Padula C.A., Roberts J.L., Weiner R.I. Immortaliziation of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 1990, 5:1-10.
116. Mishina M., Sakimura K. Conditional gene targeting on the pure C57BL/6 genetic background. Neuroscience Research 2007, 58:105-112.
117. 2+ measurements using improved cameleons. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:2135-2140.
118. 2+ based on green fluorescent proteins and calmodulin. Nature 1997, 388:882-887.
119. Mizrahi A., Lu J., Irving R., Feng G., Katz L.C. In vivo imaging of juxtaglomerluar neuron turnover in the mouse olfactory bulb. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:1912-1917.
120. Moreira P.N., Pozueta J., Perez-Crespo M., Valdivieso F., Gutierrez-Adan A., Montoliu L. Improving the generation of genomic-type transgenic mice by ICSI. Transgenic Research 2007, 16:163-168.
121. Moseley A.E., Williams M.T., Schaefer T.L., et al. Deficiency in Na, K-ATPase a isoform genes alters spatial learning, motor activity, and anxiety in mice. Journal of Neuroscience 2007, 27:616-626.
122. Moutier R., Tchang F., Caucheteux S.M., Kanellopoulos-Langevin C. Placental anomalies and fetal loss in mice, after administration of doxycycline in food for tet-system activation. Transgenic Research 2003, 12:369-373.
123. Moy S.S., Nadler J.J., Young N.B., et al. Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains. Behavioural Brain Research 2007, 176:4-20.
124. Nadeau J.H. Listening to genetic background noise. New England Journal of Medicine 2005, 352:2598-2599.
125. Nagano M., Brinster C.J., Orwig K.E., Ryu B.-Y., Avarbock M.R., Brinster R.L. Transgenic mice produced by retroviral transduction of male germ-line stem cells. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:13090-13095.
126. Nagel S.C., Hagelbarger J.L., McDonnell D.P. Development of an ER action mouse for the study of estrogens, selective ER modulators (SERMs), and xenobiotics. Endocrinology 2001, 142:4721-4728.
127. Ni H.-M., Chen X., Chen L., DiFrancesca D., Harada H., Yin X.-M. The impact of genetic background and Bid on the phenotype of Bcl-2-deficiency in mice. Apoptosis 2007, 13. 10.1007/s%2010495-007-0147-8.
128. Nord A.S., Chang P.J., Conklin B.R., et al. The international gene trap consortium website: A portal to all publicly available gene trap cell lines in mouse. Nucleic Acids Research 2006, 34:D642-D648.
129. Oitzl M.S., Reichardt H.M., Joels M., de Kloet E.R. Point mutations in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:12790-12795.
130. Oliver P.L., Bitoun E., Davies K.E. Comparative genetic analysis: The utility of mouse genetic systems for studying human monogenic disease. Mammal Genome 2007, 18:412-424.
131. Ornitz D.M., Palmiter R.D., Hammer R.E., Brinster R.L., Swift G.H., MacDonald R.J. Specific expression of an elastase-human growth hormone fusion gene in pancreatic acinar cells of transgenic mice. Nature 1985, 313:600-602.
132. Overbeek P.A., Chepelinsky A.B., Khillan J.S., Piatigorsky J., Westphal H. Lens-specific expression and developmental regulation of bacterial chloramphenicol acetyltransferase gene driven by the murine alpha A-crystallin promoter in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:7815-7819.
133. Palmiter R. Interrogation by toxin. Nature Biotechnology 2001, 19:731-732.
134. Palmiter R.D., Behringer R.R., Quaife C.J., Maxwell F., Maxwell I.H., Brinster R.L. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 1987, 50:435-443.
135. Palmiter R.D., Brinster R.L. Germ line transformation of mice. Annual Review of Genetics 1986, 20:465-499.
136. Palmiter R.D., Brinster R.L., Hammer R.E., Trumbauer M.E., Rosenfeld M.G., Birnberg N.C., Evans R.M. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 1982, 300:611-615.
137. Palmiter R.D., Norstedt G., Gelinas R.E., Hammer R.E., Brinster R.L. Metallothionein-human GH fusion genes stimulate growth of mice. Science 1983, 222:809-814.
138. Palmiter R.D., Sandgren E.P., Avarbock M.R., Allen D.D., Brinster R.L. Heterologous introns can enhance expression of transgenes in mice. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:478-482.
139. Peng S., York J.P., Zhang P. A transgenic approach for RNA interference-based genetic screening in mice. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:2252-2256.
140. Pepin M.C., Pothier F., Barden N. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 1992, 355:725-728.
141. Perry A.C., Rothman A., de las Heras J.I., Feinstein P., Mombaerts P., Cooke H.J., Wakayama T. Efficient metaphase II transgenesis with different transgene archetypes. Nature Biotechnology 2001, 19:1071-1073.
142. Pfeifer A., Ikawa M., Dayn Y., Verma I.M. Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:2140-2145.
143. Pittenger C., Huang Y.Y., Paletzki R.F., Bourtchouladze R., Scanlin H., Vronskaya S., Kandel E.R. Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory. Neuron 2002, 34:447-462.
144. Potts W., Tucker D., Wood H., Martin C. Chicken beta-globin 5'HS4 insulators to reduce variability in transgenic founder mice. Biochemical and Biophysical Research Communications 2000, 273:1015-1018.
145. Qian S., Chen H., Weingarth D., et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Molecular and Cellular Biology 2002, 22:5027-5035.
146. Ray M.K., Magdaleno S.W., Finegold M.J., DeMayo F. cis-Acting elements involved in the regulatio of mouse Clara cell-specific 10-kDa protein gene in vitro and in vivo analysis. Journal of Biological Chemistry 1995, 270:2689-2694.
147. Recillas-Targa F. Multiple strategies for gene transfer, expression, knock-down, and chromatin influence in mammalian cell lines and transgenic animals. Molecular Biotechnology 2006, 34:337-354.
148. Reichardt H.M., Kaestner K.H., Tuckermann J., et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998, 93:531-541.
149. Richards L.J., Plachez C., Ren T. Mechanisms regulating the development of the corpus callosum and its agenesis in mouse and human. Clinical Genetics 2004, 66:276-289.
150. Rohlmann A., Gotthardt M., Willnow T.E., Hammer R.E., Herz J. Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nature Biotechnology 1996, 14:1562-1565.
151. Ross S.R., Graves R.A., Greenstein A., Platt K.A., Shyu H.L., Mellovitz B., Spiegelman B.M. A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:9590-9594.
152. Rozeboom A.M., Akil H., Seasholtz A.F. Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:4688-4693.
153. Ruggiu M., Speed R., Taggart M., et al. The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. Nature 1997, 389:73-77.
154. Saito M., Iwawaki T., Taya C., et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nature Biotechnology 2001, 19:746-750.
155. Sauer B. Inducible gene targeting in mice using the Cre/lox system. Methods 1998, 14:381-392.
156. Savitt J.M., Jang S.S., Mu W., Dawson V.L., Dawson T.M. Bcl-x is required for proper development of the mouse substantia nigra. Journal of Neuroscience 2005, 25:6721-6728.
157. Sawamoto K., Nakao N., Kobayashi K., et al. Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6423-6428.
158. Schaft J., Ashery-Padan R., van der Hoeven F., Gruss P., Stewart A.F. Efficient FLP recombination in mouse ES cells and oocytes. Genesis 2001, 31:6-10.
159. Schedl A., Beermann F., Thies E., Montoliu L., Kelsey G., Schutz G. Transgenic mice generated by pronuclear injection of a yeast artificial chromosome. Nucleic Acids Research 1992, 20:3073-3077.
160. Schedl A., Montoliu L., Kelsey G., Schutz G. A yeast artifical chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature 1993, 362:258-261.
161. Scherrer G., Tryoen-Toth P., Filliol D., et al. Knockin mice expressing fluorescent d-opiod receptors uncover G protein-coupled receptor dynamics in vivo. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:9691-9696.
162. Schmidt E.E., Taylor D.S., Prigge J.R., Barnett S., Capecchi M.R. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:13702-13707.
163. Schmidt-Ullrich R., Memet S., Lilienbaum A., Feuillard J., Raphael M., Israel A. NF-κB activity in transgenic mice: Developmental regulation and tissue specificity. Development 1996, 122:2117-2128.
164. Shah N.M., Pisapia D.J., Maniatis S., Mendelsohn M.M., Nemes A., Axel R. Visualizing sexual dimorphism in the brain. Neuron 2004, 43:313-319.
165. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995, 269:234-238.
166. Sopher B.L., Thomas P.S., LaFevre-Bernt M.A., et al. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuropathy and implicated VEGF164 in the motor neuron degeneration. Neuron 2004, 41:687-699.
167. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nature Genetics 1999, 21:70-71.
168. Sousa N., Almeida F.X., Wotjak C.T. A hitchhiker's guide to behavioral analysis in laboratory rodents. Genes, Brain and Behavior 2006, 5(supplement 2):5-24.
169. Stanford W.L., Cohn J.B., Cordes S.P. Gene-trap mutagenesis: Past, present and beyond. Nature Reviews Genetics 2001, 2:756-768.
170. Stewart C.L., Schuetze S., Vanek M., Wagner E.F. Expression of retroviral vectors in transgenic mice obtained by embryo infection. EMBO Journal 1987, 6:383-388.
171. Strathdee D., Ibbotson H., Grant S.G.N. Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent. PLoS One 2006, 1:e4.
172. Strauss W.M., Dausman J., Beard C., Johnson C., Lawrence J.B., Jaenisch R. Germ line transmission of a yeast artificial chromosome spanning the murine α1 (I) collagen locus. Science 1993, 259:1904-1907.
173. Swift G.H., Hammer R.E., MacDonald R.J., Brinster R.L. Tissue-specific expression of the rat pancreatic elastase I gene in transgenic mice. Cell 1984, 38:639-646.
174. Takada T., Iida K., Awaji T., et al. Selective production of transgenic mice using green fluorescent protein as a marker. Nature Biotechnology 1997, 15:458-461.
175. Thomas K.R., Deng C., Capecchi M.R. High-fidelity gene targeting in embryonic stem cells by using sequence replacement vectors. Molecular and Cellular Biology 1992, 12:2919-2923.
176. Threadgill D.W., Dlugosz A.A., Hansen L.A., et al. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science 1995, 269:230-234.
177. Townes T.M., Lingrel J.B., Chen H.Y., Brinster R.L., Palmiter R.D. Erythroid-specific expression of human beta-globin genes in transgenic mice. EMBO Journal 1985, 4:1715-1723.
178. Trachtenberg J.T., Chen B.E., Knott G.W., Feng G., Sanes J.R., Welker E., Svoboda K. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 2002, 420:788-794.
179. Tronche F., Kellendonk C., Kretz O., et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nature Genetics 1999, 23:99-103.
180. Tully T. Toward a molecular biology of memory: The light's coming on!. Nature Neuroscience 1998, 1:543-545.
181. van der Putten H., Botteri F.M., Miller D., Rosenfeld M.G., Fan H., Evans R.M., Verma I.M. Efficient insertion of genes into the mouse germ line via retroviral vectors. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:6148-6152.
182. van Rossum E.F., Binder E.B., Majer M., et al. Polymorphisms of the glucocorticoid receptor gene and major depression. Biological Psychiatry 2006, 59:681-688.
183. van West D., Van Den Eede F., Del-Favero J., et al. Glucocorticoid receptor gene-based SNP analysis in patients with recurrent major depression. Neuropsychopharmacology 2006, 31:620-627.
184. Wagner T.E., Hoppe P.C., Jollick J.D., Scholl D.R., Hodinka R.L., Gault J.B. Microinjection of a rabbit β-globin gene in zygotes and its subsequent expression in adult mice and their offspring. Proceedings of the National Academy of Sciences of the United States of America 1981, 78:6376-6380.
185. Waterson R.H., Lindblad-Toh K., Birney E. Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420:520-562.
186. Wei Q., Lu X.Y., Liu L., et al. Glucocorticoid receptor overexpression in forebrain: A mouse model of increased emotional lability. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:11851-11856.
187. Wersinger S.R., Sannen K., Villalba C., Lubahn D.B., Rissman E.F., De Vries G.J. Masculine sexual behavior is disrupted in male and female mice lacking a functional estrogen receptor alpha gene. Hormones and Behavior 1997, 32:176-183.
188. Wetsel W.C., Valenca M.M., Merchanthaler I., et al. Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:4149-4153.
189. Whitelaw C.B., Archibald A.L., Harris S., McClenaghan M., Simons J.P., Clark A.J. Targeting expression to the mammary gland: Intronic sequences can enhance the efficiency of gene expression in transgenic mice. Transgenic Research 1991, 1:3-13.
190. Whitelaw C.B., Springbett A.J., Webster J., Clark J. The majority of G0 transgenic mice are derived from mosaic embryos. Transgenic Research 1993, 2:29-32.
191. Willis-Owen S.A.G., Flint J. The genetic basis of emotional behavior in mice. European Journal of Human Genetics 2006, 14:721-728.
192. Witkin J.W., Paden C.M., Silverman A.J. The luteinizing hormone-releasing hormone (LHRH) systems in the rat brain. Neuroendocrinology 1982, 35:429-438.
193. Wong G.T. Speed congenics: Applications for transgenic and knock-out mouse strains. Neuropeptides 2002, 36:230-236.
194. Woychik R.P., Stewart T.A., Davis L.G., D'Eustachio P., Leder P. An inherited limb deformity created by insertional mutagenesis in a transgenic mouse. Nature 1985, 318:36-40.
195. +tf/J mice are unchanged by cross-fostering with C57BL/6 mothers. International Journal of Developmental Neuroscience 2007, 25:515-521.
196. Yarus S., Hadsell D., Rosen J.M. Engineering transgenes for use in the mammary gland. Genetic Engineering (NY) 1996, 18:57-81.
197. Ye X., Han S.J., Tsai S.Y., DeMayo F.J., Xu J., Tsai M.-J., O'Malley B. Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:9487-9492.
198. Zambrowicz B.P., Imamoto A., Fiering S., Harzenberg L.A., Kerr W.G., Soriano P. Disruption of overlapping transcripts in the ROSA bgeo 26 gene trap strain leads to widespread expression of β-galactosidase in mouse embryos and hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:3789-3794.
199. Zhang X., Beaulieu J.-M., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004, 305:217.
200. Zhang X., Gainetdinov R.R., Beaulieu J.-M., et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005, 45:11-16.
201. Zimmerman L., Parr B., Lendahl U., et al. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 1994, 12:11-24.
202. Zou Y.R., Muller W., Gu H., Rajewsky K. Cre-loxP-mediated gene replacement: A mouse strain producing humanized antibodies. Current Biography 1994, 4:1099-1103.
203. - Mouse Genome Informatics. http://www.informatics.jax.org.
204. - Official website of the Nobel Foundation. http://nobelprize.org.